Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it? Caroline M. HullMark PeakmanTimothy I. M. Tree Review Open access 02 August 2017 Pages: 1839 - 1850
GLP-1/glucagon receptor co-agonism for treatment of obesity Miguel A. Sánchez-GarridoSara J. BrandtMatthias H. Tschöp Review Open access 21 July 2017 Pages: 1851 - 1861
SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials Huilin TangQi DaiJiali Han Article 19 July 2017 Pages: 1862 - 1872
Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study Elina IsokuorttiYou ZhouHannele Yki-Järvinen Article 29 June 2017 Pages: 1873 - 1882
Toe–brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria Emilie H. ZobelBernt Johan von ScholtenPeter Rossing Article 05 July 2017 Pages: 1883 - 1891
The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass Judith Aron-WisnewskyNataliya SokolovskaKarine Clément Article 21 July 2017 Pages: 1892 - 1902
Metabolic profiling of gestational diabetes in obese women during pregnancy Sara L. WhiteDharmintra Pasupathyon behalf of the UPBEAT Consortium Article Open access 01 August 2017 Pages: 1903 - 1912
Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe Aoife M. EganAkke Vellingaon behalf of the DALI Core Investigator group Article Open access 12 July 2017 Pages: 1913 - 1921
Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry Yuji KomoritaMasanori IwaseTakanari Kitazono Article 18 July 2017 Pages: 1922 - 1930
Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study Maria LönnrotKristian F. Lynchon behalf of the TEDDY Study Group Article 02 August 2017 Pages: 1931 - 1940
Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population Charlotte HolstUlrik BeckerJanne S. Tolstrup Article 27 July 2017 Pages: 1941 - 1950
Age at natural menopause and risk of type 2 diabetes: a prospective cohort study Taulant MukaEralda AsllanajOscar H. Franco Article Open access 18 July 2017 Pages: 1951 - 1960
Transplantation sites for human and murine islets Rebecca A. StokesKim ChengJenny E. Gunton Article Open access 22 July 2017 Pages: 1961 - 1971
Transplantation sites for porcine islets Rebecca A. StokesDenbigh M. SimondWayne J. Hawthorne Short Communication Open access 21 July 2017 Pages: 1972 - 1976
PIWI-interacting RNAs as novel regulators of pancreatic beta cell function Imène Sarah HenaouiCécile JacovettiRomano Regazzi Article 16 July 2017 Pages: 1977 - 1986
Proteomic characterisation reveals active Wnt-signalling by human multipotent stromal cells as a key regulator of beta cell survival and proliferation Miljan KuljaninGillian I. BellDavid A. Hess Article 14 July 2017 Pages: 1987 - 1998
ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB Michele LeducJoy RichardMagalie A. Ravier Article 18 July 2017 Pages: 1999 - 2010
MicroRNAs modulate core-clock gene expression in pancreatic islets during early postnatal life in rats Cécile JacovettiAdriana Rodriguez-TrejoRomano Regazzi Article 04 July 2017 Pages: 2011 - 2020
IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodents Aleksandar IvovicAndrei I. OprescuAdria Giacca Article 20 July 2017 Pages: 2021 - 2032
Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice Tine D. HannibalAnja Schmidt-ChristensenDan Holmberg Article Open access 28 June 2017 Pages: 2033 - 2041
Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes Rikke KruseSara G. VienbergKurt Højlund Article 18 July 2017 Pages: 2042 - 2051
Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance Laura FormentiniAlexander J. RyanRobert R. Henry Article 02 August 2017 Pages: 2052 - 2065
Why is it so difficult to measure glucagon-like peptide-1 in a mouse? Johanne A. WindeløvNicolai J. Wewer AlbrechtsenJens J. Holst Article 01 July 2017 Pages: 2066 - 2075
Chronic administration of myristic acid improves hyperglycaemia in the Nagoya–Shibata–Yasuda mouse model of congenital type 2 diabetes Tamae TakatoKai IwataFumio Sakane Article 13 July 2017 Pages: 2076 - 2083
The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study Ionut BebuBarbara H. Braffettthe DCCT/EDIC Research Group Article 16 July 2017 Pages: 2084 - 2091
The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study Khalida IsmailCalum D. MoultonStephanie A. Amiel Article Open access 03 August 2017 Pages: 2092 - 2102
Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes Valli VelayuthamPaul Z. Benitez-AguirreKim C. Donaghue Article 15 July 2017 Pages: 2103 - 2110
Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes Deoye TonadeHaitao LiuTimothy S. Kern Article 28 July 2017 Pages: 2111 - 2120
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Vincent RigalleauLaurence BlancoChristian Combe Letter 19 July 2017 Pages: 2121 - 2122
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] Giuseppe PennoEleonora RussoStefano Del Prato Letter 02 August 2017 Pages: 2123 - 2125